Developer docs
API playgroundTry for free, no card

Search company profiles

Vida Clinical Studies

Full company profile

uuid005k8kt

Namestring
Vida Clinical Studies
Legal namestring
Vida Clinical Studies
Websiteurl
vidastudies.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Vida Clinical Studies is a privately held, single-site clinical research organization (SRO) headquartered at 8560 N. Silvery Lane, Suite 101, Dearborn Heights, Michigan, with approximately 10 employees and over 10 years of operating experience in the greater Detroit/Metro Detroit area. The company runs vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and contract research organizations (CROs), while recruiting paid study volunteers directly from the local community through its website, phone, email, and an embedded StudyPulse online booking widget. Participant compensation for active studies ranges from $150 (STD medical device study) to $3,450 (acne vaccine study), with current programs spanning RSV and pneumococcal infant vaccines, a COVID+flu vaccine study, a Phase III cardiovascular trial in patients with established or high-risk atherosclerotic cardiovascular disease (ASCVD), and COVID/flu at-home diagnostic device validation.

The company's underlying technology and facility infrastructure is built around a CLIA-certified on-site laboratory with biobanking capability (-80°C and -20°C freezers, 2-8°C refrigerators), peripheral blood mononuclear cell (PBMC) processing for immunology research, and ECG and cardiovascular diagnostic equipment to support protocol-driven assessments. Vida's core operational differentiator is its deep community engagement in the ethnically diverse Dearborn/Detroit area, which the company positions as a competitive advantage for sponsors needing representative patient populations, and which was validated externally when CRIO recognized Vida as the highest enrolling site in a high-profile vaccine study. The business model is professional-services based: revenue is generated through study contracts with pharmaceutical sponsors and CROs for participant recruitment, data collection, and regulatory compliance, while participant compensation is funded by sponsors as a pass-through component of study budgets. There is no disclosed evidence of institutional investment, parent company ownership, or multi-site expansion, and the company appears to be founder/management-owned and operated.

Short descriptiontext

Vida Clinical Studies is a privately held, single-site clinical research facility in Dearborn Heights, Michigan, with ~10 employees and 10+ years of experience running vaccine, interventional, and diagnostic trials for pharmaceutical sponsors and CROs by recruiting from the diverse Detroit-area community.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDearborn Heights, United States
HQ citystring
Dearborn Heights
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, vaccine clinical trials, interventional studies, diagnostic device studies, clinical trial site management
Industry5 codes
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGACAL
Site Data Management Support (EDC/Source/SDV Readiness)
SECONDARYHLAGACAJ
Clinical Trial Sample Collection & Site Phlebotomy Services
NAICS code2 codes
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical and Diagnostic Laboratories6215
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
Product category
Clinical Research Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Clinical Trial Services
TypeProfessional Services
Description

Conduct clinical research studies on behalf of pharmaceutical sponsors and CROs. Revenue generated through study contracts for participant recruitment, data collection, and regulatory compliance.

vidastudies.com
2Study Participant Compensation
TypeProfessional Services
Description

Participants receive compensation for their involvement in clinical trials, funded by pharmaceutical sponsors as part of study budgets.

vidastudies.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Pricing details4 tiers
1Acne Vaccine Study - $3,450
ModelOtherBilling cadencePay-as-you-go
Notes

Participants aged 18-45 years receive $3,450 for participating in the Acne Vaccine Study.

vidastudies.com
2Migraine Study - $1,000+
ModelOtherBilling cadencePay-as-you-go
Notes

Adults over 18 years receive $1,000+ for participating in the Migraine Study.

vidastudies.com
3Pneumococcal Infant Vaccine Study - $1,180
ModelOtherBilling cadencePay-as-you-go
Notes

Healthy infants aged 42-90 days receive $1,180 compensation.

vidastudies.com
4STD Medical Device Study - $150
ModelOtherBilling cadencePay-as-you-go
Notes

Individuals aged 14 years and older receive $150 for STD medical device study participation.

vidastudies.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Vida Clinical Studies operates a private clinical research facility in Dearborn Heights, Michigan, conducting paid vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and CROs. The site recruits local Detroit-area volunteers—infants, adults, and families—and delivers protocol execution using on-site CLIA-certified laboratories, biobanking freezers, PBMC processing, and ECG/cardiovascular diagnostic equipment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Highest enrolling site recognition in high-profile vaccine study
Product overview1 text field

Vida Clinical Studies operates as a clinical research facility providing a unified platform of clinical trial services for pharmaceutical sponsors and CRO partners. The company offers three integrated service categories: Vaccine Studies (RSV, acne, migraine, and pneumococcal vaccines), Interventional Studies (COVID/flu vaccines and cardiovascular medications), and Diagnostic Studies (COVID/flu testing devices and STD medical devices). All services are delivered through their CLIA-certified facility in Dearborn Heights, Michigan, with on-site laboratory capabilities, diagnostic equipment, and dedicated monitoring rooms to support protocol compliance and patient enrollment.

Product and service3 records
1Vaccine Studies
CategoryClinical Research Services - Vaccine Trials
Description

Clinical trials for vaccine candidates conducted at the Dearborn Heights facility for pharmaceutical sponsors and CROs. Enrolls paid volunteers including infants, children, and adults across RSV, acne, migraine, and pneumococcal vaccine protocols. Participant compensation ranges from $1,180 to $3,450 depending on study.

2Interventional Studies
CategoryClinical Research Services - Interventional Trials
Description

Clinical trials evaluating investigational medications including COVID+flu vaccine studies and a Phase III cardiovascular study assessing the effect of an oral medication on major adverse cardiovascular events in patients with established or high-risk atherosclerotic cardiovascular disease (ASCVD). Delivered to pharmaceutical sponsors and CROs.

3Diagnostic Studies
CategoryClinical Research Services - Diagnostic Device Trials
Description

Clinical trials testing diagnostic devices including COVID/flu at-home testing devices for all ages and an STD medical device study using self-collected vaginal swabs and urine samples, with $150 compensation for STD study participants aged 14+. Delivered to pharmaceutical sponsors, CROs, and device manufacturers.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierNotableTypeOthers
Description

CRIO, a clinical research technology company, recognized Vida Clinical Studies as the highest enrolling site in a high-profile vaccine study through their case study documentation. This recognition highlights Vida's excellence in patient recruitment and clinical trial execution.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers7 records
TypeEmerging player
Description

Clinical research site organization with multiple U.S. locations focused on diverse patient recruitment for vaccine and therapeutic trials. Comparable to Vida in targeting underrepresented populations and operating community-rooted sites.

TypeDirect peer
Description

Multi-therapeutic clinical research site network with integrated recruitment, principal investigators, and dedicated facilities. Operates the same direct-to-consumer plus sponsor-channel model as Vida across multiple U.S. regions.

TypeDirect peer
Description

Multi-site clinical research site network operating integrated research facilities across the U.S. for pharmaceutical and CRO trials. Directly comparable to Vida as a Site Management Organization serving sponsors with similar vaccine, interventional, and diagnostic study offerings.

TypeDirect peer
Description

Clinical research site network running vaccine, infectious disease, and therapeutic trials across multiple U.S. locations. Similar SMO profile recruiting directly to consumers while serving pharma and CRO clients.

TypeBroad incumbent
Description

Mid-sized global CRO running full-service clinical development including site management and clinical monitoring. Competes indirectly with Vida for sponsor protocol execution but at much broader scale across geographies and therapeutic areas.

TypeDirect peer
Description

Network of clinical research sites specializing in Phase I-IV trials across multiple therapeutic areas including vaccines and CNS. Comparable SMO model delivering site-based study execution for pharma sponsors and CROs.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks4 records

Each record includes

Headline, Details, Source

Key highlights5 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vida Clinical Studies

Clinical Research Servicesvidastudies.com

Vida Clinical Studies is a privately held, single-site clinical research facility in Dearborn Heights, Michigan, with ~10 employees and 10+ years of experience running vaccine, interventional, and diagnostic trials for pharmaceutical sponsors and CROs by recruiting from the diverse Detroit-area community.

What Vida Clinical Studies does

Vida Clinical Studies is a privately held, single-site clinical research organization (SRO) headquartered at 8560 N. Silvery Lane, Suite 101, Dearborn Heights, Michigan, with approximately 10 employees and over 10 years of operating experience in the greater Detroit/Metro Detroit area. The company runs vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and contract research organizations (CROs), while recruiting paid study volunteers directly from the local community through its website, phone, email, and an embedded StudyPulse online booking widget. Participant compensation for active studies ranges from $150 (STD medical device study) to $3,450 (acne vaccine study), with current programs spanning RSV and pneumococcal infant vaccines, a COVID+flu vaccine study, a Phase III cardiovascular trial in patients with established or high-risk atherosclerotic cardiovascular disease (ASCVD), and COVID/flu at-home diagnostic device validation.

The company's underlying technology and facility infrastructure is built around a CLIA-certified on-site laboratory with biobanking capability (-80°C and -20°C freezers, 2-8°C refrigerators), peripheral blood mononuclear cell (PBMC) processing for immunology research, and ECG and cardiovascular diagnostic equipment to support protocol-driven assessments. Vida's core operational differentiator is its deep community engagement in the ethnically diverse Dearborn/Detroit area, which the company positions as a competitive advantage for sponsors needing representative patient populations, and which was validated externally when CRIO recognized Vida as the highest enrolling site in a high-profile vaccine study. The business model is professional-services based: revenue is generated through study contracts with pharmaceutical sponsors and CROs for participant recruitment, data collection, and regulatory compliance, while participant compensation is funded by sponsors as a pass-through component of study budgets. There is no disclosed evidence of institutional investment, parent company ownership, or multi-site expansion, and the company appears to be founder/management-owned and operated.

Vida Clinical Studies firmographics

Firmographics
Name
Vida Clinical Studies
Legal name
Vida Clinical Studies
Website
https://vidastudies.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Vida Clinical Studies is a privately held, single-site clinical research facility in Dearborn Heights, Michigan, with ~10 employees and 10+ years of experience running vaccine, interventional, and diagnostic trials for pharmaceutical sponsors and CROs by recruiting from the diverse Detroit-area community.
Ownership category
akta.pro rank

Vida Clinical Studies industry classification

Industry
Product category
Clinical Research Services
NAICS
Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLAGACAE
Clinical Trial Site Operations & Study Coordination
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYHLAGACAL
Site Data Management Support (EDC/Source/SDV Readiness)
SECONDARYHLAGACAJ
Clinical Trial Sample Collection & Site Phlebotomy Services

Keywords

  • Clinical research services
  • Vaccine clinical trials
  • Interventional studies
  • Diagnostic device studies
  • Clinical trial site management

Where Vida Clinical Studies is headquartered

Location

Headquarters

HQ city
Dearborn Heights
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Vida Clinical Studies business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D

Revenue model

  1. Clinical Trial Services: Conduct clinical research studies on behalf of pharmaceutical sponsors and CROs. Revenue generated through study contracts for participant recruitment, data collection, and regulatory compliance.
  2. Study Participant Compensation: Participants receive compensation for their involvement in clinical trials, funded by pharmaceutical sponsors as part of study budgets.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goAcne Vaccine Study - $3,450
OtherPay-as-you-goMigraine Study - $1,000+
OtherPay-as-you-goPneumococcal Infant Vaccine Study - $1,180
OtherPay-as-you-goSTD Medical Device Study - $150

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Vida Clinical Studies product offering

Product offering

Core offering

Vida Clinical Studies operates a private clinical research facility in Dearborn Heights, Michigan, conducting paid vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and CROs. The site recruits local Detroit-area volunteers—infants, adults, and families—and delivers protocol execution using on-site CLIA-certified laboratories, biobanking freezers, PBMC processing, and ECG/cardiovascular diagnostic equipment.

Product overview

Vida Clinical Studies operates as a clinical research facility providing a unified platform of clinical trial services for pharmaceutical sponsors and CRO partners. The company offers three integrated service categories: Vaccine Studies (RSV, acne, migraine, and pneumococcal vaccines), Interventional Studies (COVID/flu vaccines and cardiovascular medications), and Diagnostic Studies (COVID/flu testing devices and STD medical devices). All services are delivered through their CLIA-certified facility in Dearborn Heights, Michigan, with on-site laboratory capabilities, diagnostic equipment, and dedicated monitoring rooms to support protocol compliance and patient enrollment.

Differentiator

Problem solved

Functional benefit

Products and services

  • Vaccine Studies Clinical trials for vaccine candidates conducted at the Dearborn Heights facility for pharmaceutical sponsors and CROs. Enrolls paid volunteers including infants, children, and adults across RSV, acne, migraine, and pneumococcal vaccine protocols. Participant compensation ranges from $1,180 to $3,450 depending on study.
  • Interventional Studies Clinical trials evaluating investigational medications including COVID+flu vaccine studies and a Phase III cardiovascular study assessing the effect of an oral medication on major adverse cardiovascular events in patients with established or high-risk atherosclerotic cardiovascular disease (ASCVD). Delivered to pharmaceutical sponsors and CROs.
  • Diagnostic Studies Clinical trials testing diagnostic devices including COVID/flu at-home testing devices for all ages and an STD medical device study using self-collected vaginal swabs and urine samples, with $150 compensation for STD study participants aged 14+. Delivered to pharmaceutical sponsors, CROs, and device manufacturers.

Quantifiable outcome

  • Highest enrolling site recognition in high-profile vaccine study

Companies that use Vida Clinical Studies

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Vida Clinical Studies technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Vida Clinical Studies partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CRIOnotableOthersCRIO, a clinical research technology company, recognized Vida Clinical Studies as the highest enrolling site in a high-profile vaccine study through their case study documentation. This recognition highlights Vida's excellence in patient recruitment and clinical trial execution.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Vida Clinical Studies competitors and assessment

Company assessment

Peers

Emerging players

  • DM Clinical Research: Clinical research site organization with multiple U.S. locations focused on diverse patient recruitment for vaccine and therapeutic trials. Comparable to Vida in targeting underrepresented populations and operating community-rooted sites.

Direct peers

  • Accel Research Sites: Multi-therapeutic clinical research site network with integrated recruitment, principal investigators, and dedicated facilities. Operates the same direct-to-consumer plus sponsor-channel model as Vida across multiple U.S. regions.
  • Velocity Clinical Research: Multi-site clinical research site network operating integrated research facilities across the U.S. for pharmaceutical and CRO trials. Directly comparable to Vida as a Site Management Organization serving sponsors with similar vaccine, interventional, and diagnostic study offerings.
  • Benchmark Research: Clinical research site network running vaccine, infectious disease, and therapeutic trials across multiple U.S. locations. Similar SMO profile recruiting directly to consumers while serving pharma and CRO clients.
  • CenExel Clinical Research: Network of clinical research sites specializing in Phase I-IV trials across multiple therapeutic areas including vaccines and CNS. Comparable SMO model delivering site-based study execution for pharma sponsors and CROs.

Broad incumbents

  • Medpace: Mid-sized global CRO running full-service clinical development including site management and clinical monitoring. Competes indirectly with Vida for sponsor protocol execution but at much broader scale across geographies and therapeutic areas.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights5 records

Customer concentration

Vida Clinical Studies social profiles

Digital presence

Vida Clinical Studies compliance and trust

Trust signal

Compliance1 record

Vida Clinical Studies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vida Clinical Studies leadership team

Management profile

Number of profiles

Vida Clinical Studies funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vida Clinical Studies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vida Clinical Studies

What does Vida Clinical Studies do?

Vida Clinical Studies operates a private clinical research facility in Dearborn Heights, Michigan, conducting paid vaccine, interventional, and diagnostic clinical trials on behalf of pharmaceutical sponsors and CROs. The site recruits local Detroit-area volunteers—infants, adults, and families—and delivers protocol execution using on-site CLIA-certified laboratories, biobanking freezers, PBMC processing, and ECG/cardiovascular diagnostic equipment.

Is Vida Clinical Studies a public or private company?

Vida Clinical Studies is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Vida Clinical Studies founded?

Vida Clinical Studies was founded in -1. It employs 1 to 10 people.

Where is Vida Clinical Studies based?

Vida Clinical Studies is headquartered in Dearborn Heights, United States, in the North America region.

How does Vida Clinical Studies make money?

Two revenue lines are on record. Clinical Trial Services are the primary driver. The others are study Participant Compensation.

Who are Vida Clinical Studies's main competitors?

IQVIA is listed as a peer. DM Clinical Research is listed as an emerging player. Direct peers are Accel Research Sites, Velocity Clinical Research, Benchmark Research and CenExel Clinical Research. Medpace is listed as a broad incumbent.

Does Vida Clinical Studies have an API?

No public API is recorded for Vida Clinical Studies.

What industry is Vida Clinical Studies in?

Vida Clinical Studies's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAE, Clinical Trial Site Operations & Study Coordination, with a secondary code of HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs. Its NAICS code is 541714 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales